In January 2025, you said that the new diabetes and weight-loss medications called GLP-1 drugs appeared to reduce the risk of many major diseases, by reducing inflammation
FDA Approves Oral Semaglutide as the First GLP-1 Pill for Weight Loss The FDAs recent approval of oral semaglutide marks a revolutionary milestone in obesity medicine, introducing the first daily pill to deliver the powerful weight loss results previously restricted to injectable therapies
Acknowledgments We thank Kristin Marie Bivens (Institute of Social and Preventive Medicine ISPM) for her editorial assistance
The Oral GLP-1 Side Effects It turns out, most of the oral side effects of GLP-1s are a result of those pesky GI ones
The regulatory patchwork creates a situation where moving from one state to another, or switching from an employer plan to a marketplace plan, can completely change your GLP-1 coverage status
Consult with your provider to determine the best timeline for you, especially if you have used a GLP-1 for diabetes treatment
